Pituitary function in adult males receiving medroxyprogesterone acetate

W. J. Meyer, P. A. Walker, C. Wiedeking, J. Money, A. A. Kowarski, C. J. Migeon, D. S. Borgaonkar

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

The pituitary, adrenal, and gonadal functions of nine males (six XY, two XYYm and one XY/XYY) were studied after at least 6 months of medroxyprogesterone acetate (MPA) therapy for antisocial or sex-offending behavior. Five were studied both before and during therapy, four only during therapy. MPA was effective in decreasing serum gonadotropin and plasma testosterone concentrations. MPA caused no change in the 24-hour rhythm or total integrated concentration of growth hormone. The plasma cortisol circadian rhythm was suppressed but not obliterated by MPA therapy. Although a significant decrease (P< 0.001) in 24-hour integrated concentrations of plasma cortisol was also found, the rise in the plasma cortisol level after insulin-induced hypoglycemia was unchanged.

Original languageEnglish (US)
Pages (from-to)1072-1076
Number of pages5
JournalUnknown Journal
Volume28
Issue number10
DOIs
StatePublished - 1977
Externally publishedYes

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Pituitary function in adult males receiving medroxyprogesterone acetate'. Together they form a unique fingerprint.

Cite this